Clinical Scoring Systems for Adults With Acute Appendicitis

Which clinical scoring system is most accurate for risk stratification of acute appendicitis in adults?

Acute appendicitis is the most common cause of abdominal pain and requires urgent surgical intervention, with a lifetime risk between 7% and 12% in the general population.¹ Diagnosis remains a challenge because only about 40% of patients present with classic symptoms of pain migration to the right lower quadrant, nausea, and vomiting.¹ Delayed diagnosis increases the risk of perforation and peritonitis, whereas overdiagnosis leads to unnecessary appendectomy, which occurs in approximately 10% to 15% of cases.²

The Alvarado score was introduced in 1986 and is the most widely studied tool for identifying acute appendicitis.³ It incorporates six clinical features and two laboratory variables³ (Table 1^1,2). Cutoffs differ by study, but generally, a score of less than 4 makes appendicitis unlikely, 4 to 6 indicates possible acute appendicitis and imaging is recommended, and scores of 7 or greater suggest the need for early surgical consultation.⁴

The RIPASA score was developed to improve diagnostic accuracy for acute appendicitis by incorporating demographic factors and additional physical examination findings not included in the Alvarado score.⁵ It includes 14 parameters, and a score of 7.5 or greater is considered positive and should prompt surgical consultation¹ (Table 1^1,2). The RIPASA score was most extensively validated in Middle Eastern and Asian populations, although subsequent studies suggest reasonable performance in more diverse settings.² The original derivation study included a variable for identifying foreign nationals, reflecting the heterogeneous population in Singapore; this variable is often omitted in external validations and calculators used in other regions.⁵

Several additional scoring systems, including the Appendicitis Inflammatory Response, Adult Appendicitis Score, Fenyo-Lindberg score, Lintula, and Tzanakis, have been proposed. However, most of these scores have limited external validation or inconsistent performance across populations, and none have demonstrated clear superiority to RIPASA or Alvarado among adults in routine practice.²